Seeing Is Believing
LFCR is currently covered by 1 analysts with an average price target of $6.5. This is a potential upside of -$0.03 (-0.46%) from yesterday's end of day stock price of $6.53.
Lifecore Biomedical's activity chart (see below) currently has 18 price targets and 21 ratings on display. The stock rating distribution of LFCR is 16.67% HOLD and 83.33% BUY.
Analysts average stock forecasts to be materialized ratio is 69.17% with an average time for these price targets to be met of 132.17 days.
Highest price target for LFCR is $6.5, Lowest price target is $6.5, average price target is $6.5.
Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON. First documented stock forecast 10-Jan-2023.
Currently out of the existing stock ratings of LFCR, 1 are a HOLD (16.67%), 5 are a BUY (83.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Apr-2024
$6
$0.83 (16.05%)
$6
1 years 8 months 28 days ago
(03-Jan-2025)
3/3 (100%)
$-1.62 (-21.26%)
12
Buy Since 05-Sep-2024
$10
$4.83 (93.42%)
$8
1 years 10 months 9 days ago
(22-Nov-2024)
1/2 (50%)
$2.69 (36.80%)
292
What is LFCR (Lifecore Biomedical) average time for price targets to be met?
Which analyst most recently updated their price target on LFCR (Lifecore Biomedical)?
Which analyst has the most public recommendations on LFCR (Lifecore Biomedical)?
Which analyst is the currently most bullish on LFCR (Lifecore Biomedical)?
Which analyst is the currently most reserved on LFCR (Lifecore Biomedical)?